Columbia Balanced Fund Institutional 2 Class

The investment seeks high total return by investing in common stocks and debt securities. Under normal circumstances, the fund invests in a mix of equity and debt securities. Its assets are allocated among equity and debt securities (which includes cash and cash equivalents) based on an assessment of the relative risks and returns of each asset class. The fund generally will invest between 35% and 65% of its net assets in each asset class, and in any event will invest at least 25% and no more than 75% of its net assets in each asset class under normal circumstances.

Columbia Balanced Fund Institutional 2 Class trades as CLREX on NASDAQ. The company is classified in Financial Services / Asset Management and reports in USD.

The current profile places the business in Asset Management. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Columbia Balanced Fund Institutional 2 Class can be compared against peers such as Columbia Balanced Fund, Columbia Balanced Fund Institutional 3 Class, MFS International Growth I, MFS Mid Cap Value Fund - Class A, MFS Mid Cap Value Fund Class R6, T. Rowe Price Small-Cap Value Fund I Class.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $10.49B, beta of 0.92, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

CLREX currently shows total debt of N/A and beta of 0.92. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: N-CSR (2026-06-04 00:00:00), 40-17F2 (2026-05-29 00:00:00), 40-17F2 (2026-05-29 00:00:00), NPORT-P (2026-05-28 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.columbiathreadneedleus.com/investment-products/mutual-funds/columbia-balanced-fund/class-institutional2/details?cusip=19766D444

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.